Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
It is not an FDA-approved drug or dietary supplement
[8] In other words, where cagrilintide is a research-stage candidate, tirzepatide is an approved medicine with the safety labeling that approval brings
This lyophilized peptide blend is supplied in a sterile, sealed vial format intended to support laboratory handling, controlled storage, and preparation according to institutional protocols
1% AHK-Cu (Copper Tripeptide-3)
Clinical Evidence Current clinical evidence for both peptides remains notably limited in comparison to the extensive body of preclinical data
WADA does not list it explicitly but it falls under category S2 (hGH analogues)
